SGIOY实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (29 Jun 2024 @ 03:59):
Our systems believe the stock currently is overvalued by -0.03% compare to its pairs and should correct downwards.

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan...

Stats
今日成交量	213 331
平均成交量	129 788
市值	11.18B
EPS	$122.20 ( Q4 \| 2024-03-31 )
下一个收益日期	( $0 ) 2024-07-29
Last Dividend	$0.121 ( 2021-09-28 )
Next Dividend	$0 ( N/A )
P/E	11.16 (Sector) 0 (Industry) 0
ATR14	$0.0110 (0.11%)

ACRDF 0.00%

ACRHF 0.00%

APNHY 0.00%

AVTBF 0.63%

AYRWF -14.89%

BBBT 0.00%

BLMS -9.09%

CBDHF 0.00%

CBGL 0.00%

CCHWF -21.71%

CENBF 0.00%

CHALF -99.00%

CNTTQ 0.00%

CRLBF -11.73%

CRYM -1.48%

DVAXW 9 900.00%

DVLP 0.00%

EAPH 12.03%

EDXC 55.17%

EMHTF 0.00%

ESALF -2.11%

ESALY 12.50%

ETST 11.90%

GDNSF -3.00%

GLASF 0.00%

GNHAY -15.36%

GRAMF 9 900.00%

HCANF 0.00%

HKMPY 0.00%

HLUYY 0.00%

HYEX -1.11%

HYPMY 0.00%

IPSEY 1.06%

ITHUF -18.67%

JUSHF 20.00%

KGKG 0.00%

LOWLF 0.00%

LVRLF 0.00%

MILC -1.14%

MKKGY -66.67%

NLBS 0.00%

NPHC 0.00%

NPPNY 0.00%

NUNZ 7.50%

ORXOY 2.13%

PLNHF 0.00%

PZOO -26.83%

RLBD 1.82%

RWBYF 0.21%

SGIOY 0.00%

TAIPY -12.10%

TCNNF 0.00%

TEVJF 0.00%

TLGTQ -11.79%

TRSSF -7.41%

UNRV -2.59%

VEXTF -13.10%

VLNCD 0.00%

VRNOF 0.00%

相关性 (AI algo v.1.1b): Overvalued: -0.03% $9.71 paired level. (算法实时跟踪最相关股票的变化并提供即时更新)

音量相关性

長: 0.14 (neutral)

短: -0.08 (neutral)

Signal:(54.573) Neutral

Shionogi & Co., Ltd. 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Shionogi & Co., Ltd. 相关性 - 货币/商品

0.15
( neutral )

-0.09
( neutral )

0.00
( neutral )

0.09
( neutral )

-0.53
( weak negative )

-0.24
( neutral )

Shionogi & Co., Ltd. 财务报表

Annual	2024
营收:	$435.08B
毛利润:	$369.09B (84.83 %)
EPS:	$558.51

FY	2024
营收:	$435.08B
毛利润:	$369.09B (84.83 %)
EPS:	$558.51

FY	2023
营收:	$426.68B
毛利润:	$356.58B (83.57 %)
EPS:	$621.31

FY	2022
营收:	$335.14B
毛利润:	$272.41B (81.28 %)
EPS:	$378.75

Financial Reports:

No articles found.

Shionogi & Co., Ltd. Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Shionogi & Co., Ltd. Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.85 - Stable (16.96%)

Information

First Dividend	$0.124	2021-03-29
Last Dividend	$0.121	2021-09-28
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	$0.245	--
Avg. Dividend % Per Year	0.00%	--
Score	3.71	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.85
Div. Directional Score	8.95	--

Next Divdend (Est)
(2024-12-19)

$0 Estimate 0.00 %

Dividend Stability

0.04 Very Bad

Dividend Score

3.71

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
28 Sep 2021	$0.121	30 Nov -0001	30 Nov -0001	30 Nov -0001
29 Mar 2021	$0.124	30 Nov -0001	30 Nov -0001	30 Nov -0001

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
UNTC	Ex Dividend Knight	2023-09-14	Semi-Annually	0.00%
FBTT	Ex Dividend Knight	2023-09-21	Quarterly	0.00%
REMYY	Ex Dividend Junior	2023-09-26	Annually	0.00%
CKNQP	Ex Dividend Junior	2023-09-14	Quarterly	0.00%
LZRFY	Ex Dividend Junior	2023-07-03	Bi-Monthly	0.00%
AILLO	Ex Dividend Knight	2023-07-14	Semi-Annually	0.00%
HEINY	Ex Dividend Knight	2023-08-10	Annually	0.00%
SUHJY	Ex Dividend Knight	2023-11-06	Semi-Annually	0.00%
CZBT	Ex Dividend Knight	2023-09-29	Quarterly	0.00%
NSARO	Ex Dividend Junior	2023-07-07	Quarterly	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.372	1.500	2.55	3.83	[0 - 0.5]
returnOnAssetsTTM	0.114	1.200	6.19	7.43	[0 - 0.3]
returnOnEquityTTM	0.135	1.500	9.61	10.00	[0.1 - 1]
payoutRatioTTM	0.277	-1.000	7.23	-7.23	[0 - 1]
currentRatioTTM	5.86	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	5.20	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	2.67	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.00820	-1.500	9.86	-10.00	[0 - 0.6]
interestCoverageTTM	19.09	1.000	4.04	4.04	[3 - 30]
operatingCashFlowPerShareTTM	541.64	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	442.41	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.00941	-1.500	9.96	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.859	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.394	1.000	4.12	4.12	[0.1 - 0.6]
cashFlowToDebtRatioTTM	13.28	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.307	0.800	-1.286	-1.029	[0.5 - 2]
Total Score				12.06

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	2.75	1.000	9.82	0	[1 - 100]
returnOnEquityTTM	0.135	2.50	9.75	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	442.41	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0.00550	1.500	9.86	0	[0 - 0.4]
operatingCashFlowPerShareTTM	541.64	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0.277	1.500	7.23	-7.23	[0 - 1]
pegRatioTTM	0.00219	1.500	-3.32	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.355	1.000	3.63	0	[0.1 - 0.5]
Total Score				5.85

Shionogi & Co., Ltd. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Shionogi & Co., Ltd.

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Xofluza, an influenza virus drug; and Tivicay for HIV treatment. It also develops Symproic for opioid-induced constipation treatment; S-120083 for Inflammatory pain; S-010887 for Neuropathic pain; S-117957 for Insomnia; sivopixant for Neuropathic pain, Sleep Apnea Syndrome, and Refractory/unexplainedchronic cough; S-637880 for Neuropathic Low Back Pain; Zuranolone for Depression; SDT-001 for attention-deficit/hyperactivity disorder patients; BPN14770 for Fragile X syndrome and Alzheimer's disease; and S-237648 and S-309309 for Obesity. In addition, the company develops ADR-001 for Decompensated liver cirrhosis; S-723595 for NASH; S-588410 for Esophageal and Bladder cancer; S-488210 for Head and neck squamouscell carcinoma; S-588210 for Solid tumor; S-222611 for Malignant tumor; S-770108 for Idiopathic pulmonary fibrosis; SR-0379 for Cutaneous ulcer; S-005151 for Stroke and Epidermolysis bullosa; S-531011 for Solid tumor; S-0373 for Spinocerebellar ataxia; and S-600918 and S-217622 for COVID-19, as well as S-555739 for Control of the aggravation of COVID-19. Further, it offers antibody test kits for COVID-19. Shionogi & Co., Ltd. has collaboration agreements with Nagasaki University, the National Institute of Infectious Diseases, and The Kitasato University to develop antimalarial drugs. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. Shionogi & Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan.